Sponsored by eBay
bristol myers squibb | Shop on eBay
Buy and sell on the world's online marketplace. Top brands, low prices, and free shipping on many items.
https://www.bms.com/
Bristol Myers Squibb - Global Biopharmaceutical Company
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious...
bristol myers squibbglobalbiopharmaceuticalcompany
https://app.joinhandshake.com/employers/bristol-myers-squibb-16669
Bristol Myers Squibb: Read reviews and ask questions | Handshake
Learn what working and interviewing at Bristol Myers Squibb is really like. Read real reviews, ask and answer questions.
bristol myers squibbread reviewsask questionshandshake
https://www.bms.com/gb
Bristol Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
bristol myers squibbglobalbiopharmaceuticalcompany
https://www.businesswire.com/news/home/20260420374202/en/Foundation-Medicine-Expands-Existing-Collaboration-with-Bristol-Myers-Squibb-to-Develop-a-Next-Generation-Sequencing-Companion-Diagnostic-to-Identify-Patients-with-Homozygous-MTAP-Deletion
Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a...
Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to de...
bristol myers squibbfoundation medicinecollaboration with
https://adisinsight.springer.com/patents/800025994
Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt - AdisInsight
bristol myers squibbparacetamolintravenousmallinckrodtadisinsight
https://hepatitiscnewdrugs.blogspot.com/2012/03/bristol-myers-squibb-recalls-viaspan.html
Bristol Myers-Squibb recalls Viaspan over potential Bacillus contamination
bristol myers squibbrecallspotentialbacilluscontamination
https://markets.businessinsider.com/bonds/bristol-myers_squibb_codl-notes_202020-26-bond-2026-us110122cn68?miRedirects=1
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2020(20/26) Bond | Markets Insider
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2020(20/26) (US110122CN68) - All master data, key figures and real-time diagram.
bristol myers squibb
https://www.ftc.gov/legal-library/browse/cases-proceedings/0110046-bristol-myers-squibb-company-matter
Bristol-Myers Squibb Company, In the Matter of | Federal Trade Commission
Jul 7, 2021 - Bristol-Myers Squibb Company (BMS) settled charges that it engaged in illegal business practices to delay the entry of three low price generic pharmaceuticals...
bristol myers squibbin thematter ofcompany
https://projects.propublica.org/nonprofits/organizations/133127947
Bristol Myers Squibb Foundation Inc - Nonprofit Explorer - ProPublica
Since 2013, the IRS has released data culled from millions of nonprofit tax filings. Use this database to find organizations and see details like their...
bristol myers squibbfoundationincnonprofitexplorer
https://www.cbsnews.com/news/bristol-myers-squibb-buying-celgene-in-74-billion-deal/
Bristol-Myers Squibb buying Celgene in $74 billion deal - CBS News
The combined company will have nine products with more than $1 billion each in annual sales
bristol myers squibbbuyingcelgene
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bristol-myers-squibb-voluntarily-recalls-one-lot-eliquis-apixaban-5-mg-tablets
Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets | FDA
Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed...
bristol myers squibb
https://markets.businessinsider.com/bonds/bristol-myers_squibb_codl-notes_202020-26-bond-2026-us110122cn68
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2020(20/26) Bond | Markets Insider
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2020(20/26) (US110122CN68) - All master data, key figures and real-time diagram.
bristol myers squibb
https://repository.law.upenn.edu/Documents/Detail/relationship-problems-pendent-personal-jurisdiction-after-bristol-myers-squibb/526521
Relationship Problems: Pendent Personal Jurisdiction after Bristol-Myers Squibb - Intellectual Life...
Relationship Problems: Pendent Personal Jurisdiction after Bristol-Myers Squibb, Louis J. Capozzi III, University of Pennsylvania Law School L'19, Article,...
bristol myers squibbrelationship problemspersonal jurisdictionpendent
https://www.fool.com/investing/general/2014/01/15/bristols-daclatasvir-may-prove-a-winner.aspx
Bristol-Myers Squibb Co.'s Daclatasvir May Prove a Winner | The Motley Fool
Jan 15, 2014 - In the crowded market for treating hepatitis C, Bristol-Myers (BMY) may find a willing market for its promising drug daclatasvir.
bristol myers squibb
https://www.businesswire.com/news/home/20250225770037/en/Bristol-Myers-Squibb-to-Participate-in-Upcoming-Investor-Conferences
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
bristol myers squibbparticipate inupcominginvestorconferences
https://adisinsight.springer.com/patents/800022442
Nivolumab - Bristol-Myers Squibb/Ono Pharmaceuticals - AdisInsight
bristol myers squibbnivolumabonopharmaceuticalsadisinsight
https://polsky.uchicago.edu/2020/07/23/bristol-myers-squibb-inks-new-partnership-with-the-recombinant-antibody-network/
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies - Polsky...
Aug 31, 2022 - The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago, and the University of...
bristol myers squibb
https://www.businesswire.com/news/home/20220727005148/en/Bristol-Myers-Squibb-Reports-Second-Quarter-Financial-Results-for-2022
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
bristol myers squibbsecond quarterfinancial resultsreports
https://www.nasdaq.com/market-activity/stocks/bmy
Bristol-Myers Squibb Company Common Stock (BMY) Stock Price, Quote, News & History | Nasdaq
Discover real-time Bristol-Myers Squibb Company Common Stock (BMY) stock prices, quotes, historical data, news, and Insights for informed trading and...
bristol myers squibbcommon stock
https://www.fool.com/investing/2022/09/22/why-bristol-myers-squibb-stock-bounced-higher-toda/
Why Bristol Myers Squibb Stock Bounced Higher Today | The Motley Fool
Sep 22, 2022 - The big pharma stock continues to trounce the major market indexes so far this year.
bristol myers squibbthe motleystock
https://gauteg.blogspot.com/2007/05/hr-concerns-for-bristol-myers-squibb.html
Exploring The Future of Work : HR concerns for the Bristol Myers Squibb CEO
the future of workbristol myers squibb
https://portal.ct.gov/DCP/News-Releases-from-the-Department-of-Consumer-Protection/2016-News-Releases/CT-JOINS-MULTISTATE-SETTLEMENT-WITH-BRISTOL-MYERS-SQUIBB-OVER-ABILIFY-MARKETING-ALLEGATIONS
CT JOINS MULTISTATE SETTLEMENT WITH BRISTOL-MYERS SQUIBB OVER ABILIFY MARKETING ALLEGATIONS
bristol myers squibb
https://www.business-standard.com/companies/news/bristol-myers-squibb-opens-innovation-hub-worth-100-million-in-hyderabad-124022600809_1.html
Bristol Myers Squibb opens innovation hub worth $100 million in Hyderabad | Company News - Business...
bristol myers squibb
https://www.ded.uscourts.gov/opinion/bristol-myers-squibb-co-and-bristol-myers-squibb-pharma-co-v-mylan-pharmaceuticals-inc
BRISTOL-MYERS SQUIBB CO. and BRISTOL-MYERS SQUIBB PHARMA CO. v. MYLAN PHARMACEUTICALS INC., MATRIX...
bristol myers squibbmylan pharmaceuticalsco
https://adisinsight.springer.com/drugs/800042326?error=cookies_not_supported&code=81b50991-0e2c-4b51-9f93-49820decf8c4
Research programme: AAV-based gene therapies - Bristol-Myers Squibb/uniQure - AdisInsight
uniQure and Bristol-Myers Squibb (BMS) are collaborating to develop a gene therapy, based on adeno-associated virus (AAV) vector discovery and optimisation
bristol myers squibbresearch programmegene therapiesaavbased
https://temertymedicine.utoronto.ca/news/recombinant-antibody-network-partners-bristol-myers-squibb-develop-novel-therapies
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies |...
bristol myers squibbrecombinant antibodynetwork partners
https://www.bms.com/ca/en
Bristol Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
bristol myers squibbglobalbiopharmaceuticalcompany
https://www.businesswire.com/news/home/20201028005276/en/insitro-Announces-Five-Year-Discovery-Collaboration-with-Bristol-Myers-Squibb-to-Discover-and-Develop-Novel-Treatments-for-Amyotrophic-Lateral-Sclerosis-and-Frontotemporal-Dementia
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and...
insitro, a machine-learning driven drug discovery and development company, today announced that it has entered into a five-year, discovery collaboration with...
bristol myers squibb
https://support.peta.org/page/1464/action/1
Tell Bristol-Myers Squibb to Implement Non-Animal Tests | PETA
Be a voice for the animals suffering in Bristol-Myers Squibb laboratories.
bristol myers squibbanimal teststellimplementnon
https://www.ibisworld.com/australia/company/bristol-myers-squibb-australia-pty-ltd/6299/
Bristol-Myers Squibb Australia Pty Ltd - Company Profile Report | IBISWorld
Access a detailed company profile for Bristol-Myers Squibb Australia Pty Ltd. Includes financial data, executive team, industry roles, and service providers....
bristol myers squibbltd companyaustraliaptyprofile
https://www.nasdaq.com/market-activity/stocks/bmy/insider-activity
Bristol-Myers Squibb Company Common Stock (BMY) Insider Activity | Nasdaq
Find the latest information on Bristol-Myers Squibb Company Common Stock (BMY) insider activity and insider shares traded to make sound investments with...
bristol myers squibbcommon stockinsider activitycompanybmy
https://www.techtarget.com/pharmalifesciences/news/366607585/Bristol-Myers-Squibb-Announces-Commercial-Launch-of-MS-Drug
Bristol Myers Squibb Announces Commercial Launch of MS Drug | TechTarget
Bristol Myers Squibb announced that Zeposia is now commercially available in the US for the treatment of relapsing multiple sclerosis (MS).
bristol myers squibbcommercial launchannouncesmsdrug
https://vlab.stern.nyu.edu/volatility/VOL.BMY%3AUS-R.EGARCH
V-Lab: Bristol-Myers Squibb Co EGARCH Volatility Analysis
Volatility analysis of Bristol-Myers Squibb Co using a EGARCH model
bristol myers squibbvlabcoanalysis
https://www.jnj.com/media-center/press-releases/janssen-enters-immunotherapy-clinical-collaboration-with-bristol-myers-squibb-to-evaluate-daratumumab-darzalex-in-combination-with-nivolumab-opdivo
Janssen Enters Immunotherapy Clinical Collaboration with Bristol-Myers Squibb to Evaluate...
Nov 30, 2025 - Phase 1b/Phase 2 studies planned in multiple myeloma and solid tumors
bristol myers squibbclinical collaborationjanssenentersimmunotherapy
https://markets.businessinsider.com/bonds/bristol-myers_squibb_codl-notes_201919-45-bond-2045-us110122dj48
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2019(19/45) Bond | Markets Insider
BRISTOL-MYERS SQUIBB CO.DL-NOTES 2019(19/45) (US110122DJ48) - All master data, key figures and real-time diagram.
bristol myers squibb
https://adisinsight.springer.com/drugs/800086275?error=cookies_not_supported&code=5be399b1-4236-461d-934f-c9eeb1f569c2
Tumor-activated T cell engager - Bristol Myers Squibb/Janux Therapeutics - AdisInsight
Tumor-activated therapeutic is being developed by Janux Therapeutics in collaboration with Bristol Myers Squibb for the treatment of solid tumors. The company
bristol myers squibbtumoractivatedcellengager
https://adisinsight.springer.com/patents/800023201
Apixaban - Bristol-Myers Squibb/Pfizer - AdisInsight
bristol myers squibbapixabanpfizeradisinsight
https://www.prweb.com/releases/jefferson_receives_2_8_million_grant_from_the_bristol_myers_squibb_foundation/prweb15027760.htm
Jefferson Receives $2.8 Million Grant from the Bristol-Myers Squibb Foundation
PHILADELPHIA (PRWEB) December 18, 2017 -- The Bristol-Myers Squibb Foundation has awarded Thomas Jefferson University and Jefferson Health $2.8 million to...
bristol myers squibb
https://www.colorado.edu/lab/leinwand/2020/11/17/bristol-myers-squibb-acquires-myokardia-inc-biomedical-company-co-founded-cu-professor
Bristol Myers Squibb acquires MyoKardia Inc., a biomedical company co-founded by CU professor |...
bristol myers squibb
https://vlab.stern.nyu.edu/volatility/VOL.BMY%3AUS-R.SGARCH
V-Lab: Bristol-Myers Squibb Co Spline-GARCH Volatility Analysis
Volatility analysis of Bristol-Myers Squibb Co using a Spline-GARCH model
bristol myers squibbvlabcospline
https://exec.tuck.dartmouth.edu/news-insights/bristol-myers-squibb-tuck-custom-program
Bristol-Myers Squibb turns to Tuck for help launching a new marketing initiative | Tuck Executive...
When executives at Bristol-Myers Squibb decided to update their brand planning framework, they wanted to develop a training curriculum for their marketers,...
bristol myers squibb
https://www.prweb.com/releases/coumadin_for_injection_by_bristol_myers_squibb_recalled_attorneyone_monitor_and_keep_consumers_informed/prweb11998048.htm
Coumadin for Injection by Bristol-Myers Squibb Recalled: AttorneyOne Monitor and Keep Consumers...
San Diego, CA (PRWEB) July 07, 2014 -- AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the...
bristol myers squibb
https://www.prnewswire.com/news-releases/bristol-myers-squibb-commits-to-veeva-vault-crm-302562199.html
Bristol Myers Squibb Commits to Veeva Vault CRM
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM. "Technology is fundamentally...
bristol myers squibbveeva vaultcommitscrm
https://www.cafc.uscourts.gov/9-03-2021-20-2229-bristol-myers-squibb-company-v-sigmapharm-laboratories-opinion-20-2229-opinion-9-3-2021_1829263/
20-2229: BRISTOL-MYERS SQUIBB COMPANY v. SIGMAPHARM LABORATORIES [OPINION], Nonprecedential - U.S....
Sep 3, 2021 - Opinions/Orders posted: BRISTOL-MYERS SQUIBB COMPANY v. SIGMAPHARM LABORATORIES [OPINION](pdf) Appeal Number: 20-2229 Origin: DCT Nonprecedential To see more...
bristol myers squibb
https://adisinsight.springer.com/patents/800020592
Dasatinib - Bristol-Myers Squibb - AdisInsight
bristol myers squibbdasatinibadisinsight
https://www.lobbyregister.bundestag.de/inhalte-der-interessenvertretung/regelungsvorhabensuche/RV0004282
Regelungsvorhaben "Medizinforschungsgesetz (MFG, 2024)" von "Bristol-Myers Squibb GmbH & Co. KGaA"...
Medizinforschungsgesetz (MFG, 2024)
bristol myers squibbmedizinforschungsgesetzmfgvon
https://www.bms.com/media/press-releases.html
Pharmaceutical press releases & news - Bristol Myers Squibb
Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, and...
press releases newspharmaceuticalbristolmyerssquibb
https://www.bms.com/legal-notice.html
Terms and conditions - Bristol Myers Squibb
Learn more about the terms and conditions of the Bristol Myers Squibb website and information.
terms and conditionsbristolmyerssquibb
https://www.bms.com/be/privacy-policy.html
Privacy notice center - Bristol Myers Squibb
Learn more about the privacy policy of the Bristol Myers Squibb website and how we keep your information safe.
privacy notice centerbristolmyerssquibb
https://www.bms.com/patient-and-caregivers.html
Patients and caregivers - Bristol Myers Squibb
patients and caregiversbristolmyerssquibb
https://careers.bms.com/
Your Meaningful Career at Bristol Myers Squibb
Jun 18, 2026 - Discover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.
meaningfulcareerbristolmyerssquibb
https://pharma.economictimes.indiatimes.com/news/pharma-industry/janux-therapeutics-bristol-myers-enter-up-to-850-million-deal-to-develop-cancer-drug/127221520
Janux Therapeutics Partners with Bristol Myers Squibb for Up to $850 Million Cancer Drug...
Janux Therapeutics announces a collaboration with Bristol Myers Squibb to develop a new cancer treatment targeting solid tumors, with potential payments up to...
https://www.birmingham.ac.uk/news-archive/2021/university-of-birmingham-joins-drug-discovery-collaboration-with-evotec-and-bristol-myers-squibb-1
University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb -...
The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to...
university of birmingham
https://www.uschamber.com/cases/jurisdiction-and-procedure/bristol-myers-squibb-co-v-superior-court-for-the-county-of-san-francisco-2
Bristol-Myers Squibb Co. v. Superior Court for the County of San Francisco | U.S. Chamber of...
California Supreme Court decides personal jurisdiction case, eroding limits on general jurisdiction.
https://business.adobe.com/uk/blog/rewiring-marketing-at-bristol-myers-squibb
AI in pharma marketing: Lessons from Bristol Myers Squibb
Learn how Bristol Myers Squibb is scaling AI in marketing to engage healthcare professionals, drive innovation and deliver data-driven experiences in biopharma.
ai in pharmamarketing lessonsfrom bristolmyerssquibb
https://www.benzinga.com/23/12/36367426/hbm-gets-health-boost-from-drug-licensing-deals
HBM Gets Health Boost From Drug Licensing Deals - Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Dec 22, 2023 - Key Takeaways: Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million...
https://www.lebow.drexel.edu/academics/departments/decision-sciences-and-mis/seminars/2019/10/11/Amina-Shahzad-Market-Supply-Planner-at-Bristol-Myers-Squibb
Amina Shahzad, Market Supply Planner at Bristol-Myers Squibb | Drexel University's LeBow College of...
Decision Sciences and MIS guest speaker, Amina Shahzad, will discuss her industry experience and tools used in the Supply Chain industry.
https://newsroom.haas.berkeley.edu/magazine/summer-2024/chris-boerner/
Chris Boerner, PhD 02, Board Chair & CEO, Bristol Myers Squibb - Haas News | UC Berkeley Haas
Aug 25, 2025 - How does a kid from Arkansas who hated science and wanted to be a professor end up leading a Fortune 100 biopharmaceutical company? By pursuing meaningful work...
https://resources.nvidia.com/en-us-nvidia-ai-enterprise/computational-scienc?lx=faAZxQ
Customer Story: Computational Science Accelerates Research Innovation at Bristol Myers Squibb
BMS and NVIDIA worked together to establish a centralized, modern infrastructure to accelerate drug discovery using NVIDIA DGX SuperPOD, managed by Equinix and...
customer storycomputational scienceresearch innovationaccelerates
https://www.fool.com/investing/2020/07/19/if-you-invested-1000-in-bristol-myers-squibb-durin.aspx
If You Invested $1,000 in Bristol Myers Squibb During The Last Recession, This Is How Much You...
Jul 19, 2020 - How much has this healthcare stock returned since 2008?
https://archives.lib.duke.edu/catalog/gothaminc_aspace_ref1181_592
1164. Laurence Charles Free and Lawson. Bristol Myers Squibb. Drackett Co. Renuzit Freshell. BMIR...
https://business.adobe.com/blog/rewiring-marketing-at-bristol-myers-squibb
AI in pharma marketing: Lessons from Bristol Myers Squibb
Learn how Bristol Myers Squibb is scaling AI in marketing to engage healthcare professionals, drive innovation, and deliver data-driven experiences in...
ai in pharmamarketing lessonsfrom bristolmyerssquibb
https://hcrenewal.blogspot.com/2011/09/director-of-bristol-myers-squibb-to-run.html
Health Care Renewal: Director of Bristol-Myers-Squibb to Run Weill Cornell Medical School
How the New York Times reported on a change in leadership at one New York medical school has made one issue of interest to Health Care Renew...
health care renewal
https://www.med.unc.edu/medicine/news/bristol-myers-squibb-foundation-provides-1-7-million-grant-to-unc-school-of-medicine-to-fund-program-streamlining-afib-care-education-for-underserved-populations/
Bristol-Myers Squibb Foundation Provides $1.7 million grant to UNC School of Medicine to fund...
Jun 6, 2023 - Atrial fibrillation hospitalizations reduced by 30 percentage points in first year of program.
https://www.hcp-portal.nl/
HCP Portal BMS - Home | Bristol Myers Squibb
hcp portalbmsbristolmyerssquibb